1. Home
  2. MIST vs WALD Comparison

MIST vs WALD Comparison

Compare MIST & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.50

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$1.50

Market Cap

179.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIST
WALD
Founded
2003
1988
Country
Canada
United Kingdom
Employees
N/A
364
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
176.3M
179.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MIST
WALD
Price
$1.50
$1.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$8.00
$2.00
AVG Volume (30 Days)
1.4M
1.3M
Earning Date
05-13-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,915.14
$9.89
Revenue Next Year
N/A
$4.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.72
52 Week High
$3.06
$3.22

Technical Indicators

Market Signals
Indicator
MIST
WALD
Relative Strength Index (RSI) 33.77 59.10
Support Level $1.40 $0.79
Resistance Level $2.01 $2.08
Average True Range (ATR) 0.12 0.19
MACD -0.05 0.07
Stochastic Oscillator 6.36 67.20

Price Performance

Historical Comparison
MIST
WALD

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Share on Social Networks: